Related references
Note: Only part of the references are listed.Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Kai Wang et al.
CLINICAL INFECTIOUS DISEASES (2021)
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Katharine H. D. Crawford et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses
Geoffrey J. Gorse et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
Paul Kellam et al.
JOURNAL OF GENERAL VIROLOGY (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Abishek Chandrashekar et al.
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
Emilie Seydoux et al.
IMMUNITY (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
COVID-19 Vaccines: Warp Speed Needs Mind Melds, Not Warped Minds
John P. Moore et al.
JOURNAL OF VIROLOGY (2020)
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Eskild Petersen et al.
LANCET INFECTIOUS DISEASES (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
Wei Deng et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
Larry L. Luchsinger et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection
Michael J. Carter et al.
NATURE MEDICINE (2020)
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing et al.
NATURE MEDICINE (2020)
Seasonal coronavirus protective immunity is short-lasting
Arthur W. D. Edridge et al.
NATURE MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
Guillaume Beaudoin-Bussieres et al.
MBIO (2020)
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
Suzanne Pickering et al.
PLOS PATHOGENS (2020)
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
Fan Wu et al.
JAMA INTERNAL MEDICINE (2020)
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
Anita S. Iyer et al.
SCIENCE IMMUNOLOGY (2020)
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Jeremie Prevost et al.
CELL REPORTS MEDICINE (2020)
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients
Nisreen M. A. Okba et al.
EMERGING INFECTIOUS DISEASES (2020)
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
Pyoeng Gyun Choe et al.
EMERGING INFECTIOUS DISEASES (2017)
An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
K. Grehan et al.
METHODSX (2015)
Antibody Dynamics of 2009 Influenza A (H1N1) Virus in Infected Patients and Vaccinated People in China
Ming Wang et al.
PLOS ONE (2011)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Disappearance of antibodies to SARS-associated coronavirus after recovery
Wu-Chun Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
N Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance
HY Mo et al.
RESPIROLOGY (2006)
Share Paper
